Job for M.Pharm, M.Sc as Junior Research Fellow at BITS

The Birla Institute of Technology & Science, BITS Pilani is an all-India Institute for higher education. The primary motive of BITS is to “train young men and women able and eager to create and put into action such ideas, methods, techniques and information”.

The Institute is a dream come true of its founder late Mr G.D.Birla – an eminent industrialist, a participant in Indian freedom struggle and a close associate of the Father of Indian Nation late Mr. Mohandas Karamchand Gandhi (Mahatma Gandhi).

Applications are invited from suitable candidates for Junior Research Fellow (JRF) to work on the following project sponsored by Council of Scientific and Industrial Research (CSIR), under the supervision of Dr. K V G Chandra Sekhar, Department of Chemistry BITS-Pilani, Hyderabad Campus.

Title of the project :Design, Synthesis and Biological Evaluation of 1,2,3-triazole Hybrids as Novel Quorum Sensing Inhibitors
Duration of the project : Three years

Fellowship amount : Rs.31000/- + 24% HRA (Rs.7440/-)
Eligibility requirements : M.Sc.(Chemistry) / M.Pharm or equivalent degree with 55% marks and passing of NET/GATE/GPAT test.
Age : Maximum 28 years

Interested candidates with the above mentioned qualification can send the applications on a plain paper giving detailed information about the educational qualifications, research experience and published research papers if any, by 14th July 2021, to the PI, Dr. K V G Chandra Sekhar via email: kvgc@hyderabad.bits-pilani.ac.in or by post to the address given below.

Please note that only qualified and suitable candidates will be called for interview to be held though google meet in the third or fourth week of July 2021.

Shortlisted candidates will be mailed the date and time along with the google meet link. Selected candidate may be permitted to register for Ph.D programme of BITS, Pilani, subject to the fulfillment of the requirements.

K V G Chandra Sekhar
Associate Professor, Department of Chemistry,
BITS-Pilani, Hyderabad campus,
Medchal District, Kapra Mandal
Hyderabad-500078

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit